Lung Cancers Completed Phase 2 Trials for Interferon alfa (DB05258)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002475Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerTreatment
NCT00002470Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid TumorsTreatment
NCT00002506Isotretinoin Plus Interferon in Treating Patients With Recurrent CancerTreatment